Hempelmann U, Haag-Weber M, Hörl W H, Tschesche H
Department of Biochemistry, University of Bielefeld, Federal Republic of Germany.
Transpl Int. 1991 Apr;4(1):26-30. doi: 10.1007/BF00335512.
The concentration of the metalloproteinases type I collagenase and gelatinase was measured in isolated polymorphonuclear leukocytes (PMNLs) of renal transplant recipients treated either with cyclosporin A (CyA) and prednisolone (Pr) (n = 8) or azathioprine (Aza) and Pr (n = 8), and of healthy subjects (n = 12). PMNLs of CyA- and Aza-treated transplant patients displayed markedly higher gelatinase content (2427 +/- 489 and 3284 +/- 357 ng/10(7) cells) than PMNLs of controls (528 +/- 83 ng/10(7) cells). There was also a higher content of type I collagenase in PMNLs (3374 +/- 292 ng/10(7) cells) of Aza-treated patients and significantly elevated levels in PMNLs of patients receiving CyA (3625 +/- 229 ng/10(7) cells) compared with healthy subjects (2878 +/- 151 ng/10(7) cells). In contrast, neutrophil lactoferrin content was lower in transplant patients. Thus, immunosuppressive drugs may reduce the release of leukocyte proteinases, which are known for their deleterious role in proteolytic tissue and matrix breakdown. In vitro, the effects of different immunosuppressive drugs on the release of lactoferrin, collagenase and gelatinase were investigated on FMLPNTL-stimulated PMNLs isolated from healthy subjects. CyA but not Aza or Pr caused inhibition of gelatinase, collagenase and lactoferrin release.
在接受环孢素A(CyA)和泼尼松龙(Pr)治疗的肾移植受者(n = 8)、硫唑嘌呤(Aza)和Pr治疗的肾移植受者(n = 8)以及健康受试者(n = 12)的分离多形核白细胞(PMNLs)中,测量了金属蛋白酶I型胶原酶和明胶酶的浓度。接受CyA和Aza治疗的移植患者的PMNLs显示出比对照组(528 +/- 83 ng/10(7)细胞)明显更高的明胶酶含量(2427 +/- 489和3284 +/- 357 ng/10(7)细胞)。接受Aza治疗的患者的PMNLs中I型胶原酶含量也更高(3374 +/- 292 ng/10(7)细胞),与健康受试者(2878 +/- 151 ng/10(7)细胞)相比,接受CyA治疗的患者的PMNLs中该酶水平显著升高(3625 +/- 229 ng/10(7)细胞)。相比之下,移植患者的中性粒细胞乳铁蛋白含量较低。因此,免疫抑制药物可能会减少白细胞蛋白酶的释放,而白细胞蛋白酶在蛋白水解组织和基质分解中具有有害作用。在体外,研究了不同免疫抑制药物对从健康受试者分离的经FMLPNTL刺激的PMNLs中乳铁蛋白、胶原酶和明胶酶释放的影响。CyA而非Aza或Pr导致明胶酶、胶原酶和乳铁蛋白释放受到抑制。